Changes in amine metabolism produced by antidepressant drugs. 1965

G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell

UI MeSH Term Description Entries
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D013566 Sympathomimetics Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Amines, Sympathomimetic,Sympathomimetic,Sympathomimetic Agent,Sympathomimetic Drug,Sympathomimetic Agents,Sympathomimetic Drugs,Sympathomimetic Effect,Sympathomimetic Effects,Agent, Sympathomimetic,Agents, Sympathomimetic,Drug, Sympathomimetic,Drugs, Sympathomimetic,Effect, Sympathomimetic,Effects, Sympathomimetic,Sympathomimetic Amines

Related Publications

G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
January 1962, Archivos del Instituto de Cardiologia de Mexico,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
May 1974, The Journal of nervous and mental disease,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
January 1971, Xenobiotica; the fate of foreign compounds in biological systems,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
February 2006, Expert review of neurotherapeutics,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
January 1984, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
October 1964, The American journal of physiology,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
September 2003, Molecular psychiatry,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
July 1966, Molecular pharmacology,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
January 1970, Comptes rendus des seances de la Societe de biologie et de ses filiales,
G W Ashcroft, and D Eccleston, and F Knight, and E J McDougall, and J L Waddell
January 1985, British journal of anaesthesia,
Copied contents to your clipboard!